The diagnosis of Alzheimer’s disease: an update and current controversies

Vol. 32 No. 3 (2022)
Published: 6 December 2022
Alzheimer, diagnosi, biomarcatori, demenza mista
Abstract Views: 90
PDF: 95
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Alfredo Costa
alfredo.costa@unipv.it
1) Dipartimento di Scienze del Sistema Nervoso e del Comportamento, Università di Pavia. 2) Unità Complessa Neurologia del Comportamento e Centro Disturbi Cognitivi e Demenze (CDCD), Istituto Neurologico Nazionale IRCCS Mondino, Pavia., Italy.
Giulia Perini
1) Dipartimento di Scienze del Sistema Nervoso e del Comportamento, Università di Pavia. 2) Unità Complessa Neurologia del Comportamento e Centro Disturbi Cognitivi e Demenze (CDCD), Istituto Neurologico Nazionale IRCCS Mondino, Pavia., Italy.
Camillo Imbimbo
1) Dipartimento di Scienze del Sistema Nervoso e del Comportamento, Università di Pavia. 2) Unità Complessa Neurologia del Comportamento e Centro Disturbi Cognitivi e Demenze (CDCD), Istituto Neurologico Nazionale IRCCS Mondino, Pavia., Italy.
Lucia Scanu
1) Dipartimento di Scienze del Sistema Nervoso e del Comportamento, Università di Pavia. 2) Unità Complessa Neurologia del Comportamento e Centro Disturbi Cognitivi e Demenze (CDCD), Istituto Neurologico Nazionale IRCCS Mondino, Pavia., Italy.
Matteo Cotta Ramusino
1) Dipartimento di Scienze del Sistema Nervoso e del Comportamento, Università di Pavia. 2) Unità Complessa Neurologia del Comportamento e Centro Disturbi Cognitivi e Demenze (CDCD), Istituto Neurologico Nazionale IRCCS Mondino, Pavia., Italy.

 The chapter of the diagnosis of Alzheimer’s disease (AD), almost unchanged since the early 80’s, has been recognizing over the last years a revival of scientific and clinical  interest, following increasing advances, and currently represents one of the main developing fields of neurological research. In this review we report the most recent evidence in the field, mainly based on the use of neurobiological markers of disease, as well as  the current most debated issues, such as the impact of markers on the diagnostic workup and their incremental diagnostic value with respect to early diagnosis in typical cases and in those characterized by comorbidities or association with brain vascular pathology (mixed forms).

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

How to Cite

1.
Costa A, Perini G, Imbimbo C, Scanu L, Cotta Ramusino M. The diagnosis of Alzheimer’s disease: an update and current controversies. Confinia Cephalal [Internet]. 2022 Dec. 6 [cited 2024 Dec. 3];32(3):e2022023. Available from: https://www.confiniacephalalgica.com/site/article/view/13993

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.